News|Podcasts|October 7, 2022
Episode 74: Prescription Digital Therapeutics for Insomnia
Author(s)Matt Hoffman
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Yuri Maricich, MD, MBA. [LISTEN TIME: 30 minutes]
Advertisement
Episode 74 of the NeurologyLive®
The Mind Moments® podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.
Episode 74, "Prescription Digital Therapeutics for Insomnia," features an exclusive interview with Yuri Maricich, MD, MBA, internal medicine physician, and chief medical officer and head of development, Pear Therapeutics. He joined the show to discuss the current use of digital therapeutics in insomnia such as cognitive behavioral therapy, the state of education and treatment for the sleep disorder, some of the challenges in care, and more.
This episode is brought to you by Medical World News™. Check out new episodes of a variety of shows, airing every single day, only on
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
Alzheimer Disease Agent Lecanemab Shows Reduction in CDR-Sum of Boxes in Clarity AD Verdiperstat Fails to Differentiate From Placebo in Critical HEALEY ALS Platform Trial AMX0035 Approved for the Treatment of ALS CNM-Au8 Shows Survival Benefit in HEALEY ALS Trial, But Fails to Meet End Points
EPISODE BREAKDOWN
1:15 – The positives of digital therapeutics in insomnia care
3:50 – Overview of a recent study from Maricich and colleagues
8:40 – Prioritization of sleep in clinical care
11:20 – Lack of clinical use of prescription digital therapeutics
13:05 – Neurology News Minute
15:30 – Differences for CBT-I among treatment-naïve individuals
18:05 – Use of CBT-I as a supplementary treatment tool
20:10 – Research needs and ongoing efforts
23:15 – What clinicians need to know about CBT-I and digital therapeutics
25:50 – Closing thoughts
Hoping to listen on your favorite podcast app? See below:
REFERENCES
1. Forma F, Knight TG, Thorndike FP, et al. Real-World Evaluation of Clinical Response and Long-Term Healthcare Resource Utilization Patterns Following Treatment with a Digital Therapeutic for Chronic Insomnia. Clinicoecon Outcomes Res. 2022;14:537-546. doi:10.2147/CEOR.S368780
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
NLRP3 Inhibitor VTX3232 Well Tolerated, Improves Parkinson Symptoms in Phase 2a Trial
2
Exploring the Role of Aerobic Exercise in Promoting Remyelination in Multiple Sclerosis: Lindsey Wooliscroft, MD, MS
3
Ruptured vs Unruptured Aneurysms: Practical Decision Making with Guilherme Dabus, MD
4
Bilateral MR-Guided Focused Ultrasound Shows Benefit for Managing Parkinson Motor Complications in Phase 3 Trial
5
